Drawing for POLYPLUS

USPTO serial 79292615

POLYPLUS

Reviewed by CopyMark Law Group

Reg. 6413661Status 700Renewal
Filing date
Status date
Registration date
Jul 13, 2021
Examiner
ALLEN, BIANCA LEIGH
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with POLYPLUS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,046*

Plus Government fees of $1,300

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Pina Campagna

Pina Campagna Carter, DeLuca and Farrell LLP576 Broad Hollow Rd.Melville, NY 11747UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemical and biochemical products in the nature of preparations for scientific use and for research, other than for medical or veterinary use; chemical and biochemical products in the nature of preparations for scientific use and for research in the field of genetics, for the transfer of biological molecules into living cells, integration of foreign nucleic acids into the genome of living cells and production of transfected cells, cell lines, recombinant proteins, peptides, antibodies, viruses and/or pseudo-viral particles, other than for medical or veterinary use; chemical preparations, agents and reagents for scientific use and for scientific research for genetic diagnosis; chemical and biochemical test kits for scientific laboratory use and for research use containing preparations, agents and reagents, for life science research, virus, protein, antibody production and in vivo injection; chemical and biochemical test kits for scientific laboratory use and for research use containing preparations, agents and reagents in the field of genetics, for the transfer of biological molecules into living cells, integration of foreign nucleic acids into the genome of living cells and production of transfected cells, cell lines, recombinant proteins, peptides, antibodies, viruses and/or pseudo-viral particlesACTIVE—
005Chemicals and biochemical for medical and clinical use, namely, chemical and biochemical preparations for genetic diseases; chemicals and biochemical for medical and clinical use in the field of genetics, namely, chemical and biochemical preparations for transferring biological molecules into living cells, integrating foreign nucleic acids into the genome of living cells and producing transfected cells, cell lines, recombinant proteins, peptides, antibodies, viruses and/or pseudo-virus particles for genetic diseases; chemical preparations for medical use for research and for genetic diagnostics, namely, for genetic diseases; diagnostic agents for medical use for research and for genetic diagnostics; reagents for medical use for research and for genetic diagnostics; chemical and biochemical diagnostic reagent test kits for medical and clinical use comprised of medical diagnostic preparations, agents and reagents for use in disease testing; diagnostic assay kits and chemical and biochemical diagnostic test kits, all for medical and clinical use in the field of genetics, comprised of preparations, agents and reagents for transferring biological molecules into living cells, integrating foreign nucleic acids into the genome of living cells and producing transfected cells, cell lines, recombinant proteins, peptides, antibodies, viruses and/or pseudo-virus particles, for use in disease testing; pharmaceutical products for the treatment of genetic diseases; medicines for the treatment of genetic diseases; medical and veterinary diagnostic preparations; sanitary products for medical purposes, namely, sanitary preparations for medical useACTIVE—
035Retail and wholesale store services, including online, of transfection agents, products, agents and reagents for scientific and clinical research, in particular in the field of geneticsACTIVE—
042Chemical and biochemical analyses; genetic analyses for scientific research purposes; structural and functional analysis of genomes; analyses in the field of molecular biology; scientific analyses and research in the field of transfection; software design, computer software design in the field of scientific research and genetic analyses; consulting in relation to research and development of transfections agents and agents, reagents and chemicals and biochemical used in the field of genetics; development of pharmaceutical products; scientific development of transfection agents; development of new products in the field of gene therapy; computer-aided scientific testing of DNA samples for diagnostic purposes; laboratory research in the field of genetics; conducting clinical trials for others for pharmaceutical and genetic products; scientific research in the field of medicines; scientific research in the field of genetics and genetic engineering; scientific research for medical purposes in the field of genetics and genetic engineering; services of a genetic research laboratory, namely, genetic testing for scientific research purposes and development of gene therapies for medical purposes; research and development of new products for third parties; scientific testing services in the field of geneticsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 13, 2026REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jan 1, 2026ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Dec 11, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 30, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 31, 2021ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Dec 26, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 9, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 9, 2021FIMPFINAL DISPOSITION PROCESSED—
Oct 13, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 13, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 27, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 27, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 25, 2021GPNXNOTIFICATION PROCESSED BY IB—
Apr 7, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 7, 2021OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Apr 7, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 24, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 8, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 8, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 8, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 4, 2020RFNTREFUSAL PROCESSED BY IB—
Sep 11, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 11, 2020RFRRREFUSAL PROCESSED BY MPU—
Sep 10, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 9, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 3, 2020RFRRREFUSAL PROCESSED BY MPU—
Sep 2, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 1, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 1, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 1, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 28, 2020DOCKASSIGNED TO EXAMINER—
Aug 28, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 27, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance